AMN Healthcare Services reports developments in healthcare workforce solutions and staffing services for healthcare organizations across the United States. Recurring updates cover quarterly results, earnings calls, revenue trends, gross margin, cash flow, debt, and outlook commentary across Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions.
Company news also tracks travel nurse staffing, labor disruption staffing, allied staffing, international nurse placement, search, managed service provider activity, language services, workforce technology, and market demand from healthcare systems. AMN's common stock trades on the New York Stock Exchange under the symbol AMN.
Summary not available.
AMN Healthcare Services (NYSE: AMN) reported record financial results for Q1 2021, with revenue of $885.9 million, a 47% increase from Q1 2020. Net income surged 443% to $70.4 million, translating to diluted EPS of $1.47. Key growth drivers included nurse staffing and language services, with operating cash flow of $39 million. The company completed the acquisition of Synzi Holdings to enhance its virtual care offerings. Looking ahead, AMN forecasts Q2 2021 revenue between $810 - $830 million, indicating strong growth momentum.
AMN Healthcare (NYSE: AMN) released its 2020 Corporate Social Responsibility (CSR) Report, detailing efforts made during unprecedented challenges, including the pandemic. The report highlights key achievements in community investment, diversity initiatives, and environmental responsibilities. In 2020, AMN made nearly 50,000 placements of healthcare professionals, addressing critical demand during COVID-19. The report also notes a 56% female representation on its Board of Directors, placing AMN in the top 2% of publicly traded companies for diversity.
AMN Healthcare Services, Inc. (NYSE: AMN) will discuss its Q1 2021 financial results on May 6, 2021, at 5:00 p.m. ET, following an earnings release at approximately 4:15 p.m. ET. A live webcast will be available on the company's website. Participants can join via telephone using the provided numbers. The press release emphasizes AMN's role as a leader in total talent solutions, catering to various healthcare settings to optimize workforce efficiency and improve patient outcomes. For more details, visit www.amnhealthcare.com.
Summary not available.
AMN Healthcare Services, Inc. (NYSE: AMN) reported its Q4 and full-year 2020 financial results, highlighting a consolidated revenue of $631.3 million for Q4, an 8% increase year-over-year, and a record full-year revenue of $2.39 billion, also up 8%. Net income fell to $9.3 million, down 66%, with diluted EPS of $0.19. However, adjusted diluted EPS rose by 18% to $1.00. The company experienced strong demand in its Nurse and Allied Solutions segment, with travel nurse revenue up 23% year-over-year. They project a revenue growth of 33-36% for Q1 2021.
AMN Healthcare has been recognized in HRO Today’s Baker’s Dozen Customer Satisfaction Ratings, ranking in the top ten for total workforce solutions. This ranking is based on customer surveys and highlights AMN as the sole healthcare-focused company among the leaders across all industries. AMN's President and CEO, Susan Salka, emphasized the importance of innovation and client-focused solutions in maintaining high-quality patient care. The ratings encompass criteria such as overall leadership, service breadth, deal size, and service quality, with AMN excelling in each category.
AMN Healthcare Services, Inc. (NYSE: AMN) is set to release its fourth quarter and full year 2020 financial results on February 18, 2021, at approximately 4:15 p.m. Eastern Time. A conference call discussing the results will follow at 5:00 p.m. Eastern Time, accessible via the company's website or by telephone. The company focuses on total talent solutions for healthcare organizations, providing a wide range of staffing and workforce management services. AMN Healthcare emphasizes diversity, equality, and inclusion in its operations.
AMN Healthcare Services announced preliminary unaudited consolidated revenues for Q4 2020, expected between $623 million and $628 million, exceeding prior guidance of $575 million to $585 million. The results reflect strong demand across all reportable segments, particularly in the Nurse and Allied Solutions segment. AMN expects operating margin between 7.6% and 8.1% and adjusted EBITDA margin between 13.3% and 13.8%. CEO Susan Salka and CFO Brian Scott will present at the J.P. Morgan Healthcare Conference on January 12, 2021, with further details to be provided in February.
Summary not available.